Showing results (61-70 of 126) with videos related to

Sort By:
Pageof 13
The New England Journal of Medicine|July 12, 2014
Effects of extended-release niacin with laropiprant in high-risk patients, Martin J Landray, Richard Haynes, et al.
Spine|June 5, 2007
Variation in care among spinal deformity surgeons: results of a survey of the Shriners hospitals for childrenJames O Sanders, Richard Haynes, Don Lighter, et al.
Heart (British Cardiac Society)|August 7, 2017
A policy model of cardiovascular disease in moderate-to-advanced chronic kidney diseaseIryna Schlackow, Seamus Kent, William Herrington, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 12, 2014
Evaluating the contribution of the cause of kidney disease to prognosis in CKD: results from the Study of Heart and Renal Protection (SHARP)Richard Haynes, Natalie Staplin, Jonathan Emberson, et al.
BMC Nephrology|May 1, 2015
What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease?Seamus Kent, Iryna Schlackow, Jingky Lozano-Kühne, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 7, 2016
The Safety and Efficacy of Mineralocorticoid Receptor Antagonists in Patients Who Require Dialysis: A Systematic Review and Meta-analysisKevin Quach, Lyubov Lvtvyn, Colin Baigent, et al.
European Journal of Heart Failure|June 29, 2021
Cardiac, renal, and metabolic effects of sodium-glucose co-transporter 2 inhibitors: a position paper from the European Society of Cardiology ad-hoc task force on sodium-glucose co-transporter 2 inhibitorsWilliam G Herrington, Gianluigi Savarese, Richard Haynes, et al.
British Journal of Haematology|May 30, 2019
Long term outcomes in monoclonal gammopathy of renal significanceAkhil Khera, Fotios Panitsas, Faouzi Djebbari, et al.
JAMA Network Open|March 2, 2019
Assessment of Vascular Event Prevention and Cognitive Function Among Older Adults With Preexisting Vascular Disease or Diabetes: A Secondary Analysis of 3 Randomized Clinical TrialsAlison Offer, Matthew Arnold, Robert Clarke, et al.
Kidney International|November 18, 2017
Lowering LDL cholesterol reduces cardiovascular risk independently of presence of inflammationBenjamin C Storey, Natalie Staplin, Richard Haynes, et al.
Pageof 13